Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8AKN

Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the terminating ribosome

This is a non-PDB format compatible entry.
Summary for 8AKN
Entry DOI10.2210/pdb8akn/pdb
Related8AM9 8ANA
EMDB information15488 15523 15533
Descriptor50S ribosomal protein L33, 30S ribosomal protein S4, 30S ribosomal protein S5, ... (62 entities in total)
Functional Keywordse.coli, 70s, drosocin, dro1, antimicrobial peptide, proline-rich, pramp, release factor 1, rf1, ribosome
Biological sourceEscherichia coli BW25113
More
Total number of polymer chains57
Total formula weight2240074.65
Authors
Koller, T.O.,Morici, M.,Wilson, D.N. (deposition date: 2022-07-30, release date: 2023-03-08, Last modification date: 2025-03-12)
Primary citationKoller, T.O.,Morici, M.,Berger, M.,Safdari, H.A.,Lele, D.S.,Beckert, B.,Kaur, K.J.,Wilson, D.N.
Structural basis for translation inhibition by the glycosylated drosocin peptide.
Nat.Chem.Biol., 19:1072-1081, 2023
Cited by
PubMed Abstract: The proline-rich antimicrobial peptide (PrAMP) drosocin is produced by Drosophila species to combat bacterial infection. Unlike many PrAMPs, drosocin is O-glycosylated at threonine 11, a post-translation modification that enhances its antimicrobial activity. Here we demonstrate that the O-glycosylation not only influences cellular uptake of the peptide but also interacts with its intracellular target, the ribosome. Cryogenic electron microscopy structures of glycosylated drosocin on the ribosome at 2.0-2.8-Å resolution reveal that the peptide interferes with translation termination by binding within the polypeptide exit tunnel and trapping RF1 on the ribosome, reminiscent of that reported for the PrAMP apidaecin. The glycosylation of drosocin enables multiple interactions with U2609 of the 23S rRNA, leading to conformational changes that break the canonical base pair with A752. Collectively, our study reveals novel molecular insights into the interaction of O-glycosylated drosocin with the ribosome, which provide a structural basis for future development of this class of antimicrobials.
PubMed: 36997646
DOI: 10.1038/s41589-023-01293-7
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.3 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon